Women’s sex drive can be boosted with testosterone. Long-term risks need to be studied.

sexual health x
Image: Health Journal
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

An absence of desire is not an inevitable facet of aging for women, [endocrinologist Susan] Davis says. There’s a name for the condition in which women lose that spontaneous urge and interest: hypoactive sexual desire disorder, one form of FSD.

Previous studies have suggested that testosterone may be an effective therapy for low sexual desire in women, but data on other impacts, such as mood, and on the optimal delivery method were limited. Last week Davis and her colleagues published results in Lancet Diabetes & Endocrinology confirming that for women with this condition, testosterone therapy can be effective. Unlike Viagra, it is not an acute treatment for overcoming physical difficulties and triggering in-the-moment arousal but rather a method of reinstating a desire for sex, Davis says.

Related article:  'Next time we might not be so lucky': The coronavirus shows why we need to learn more about viral threats

Both men and women naturally produce testosterone, which wanes with age in both sexes, contributing to dwindling sexual urges. It is not surprising that the effects of testosterone replacement in women echo those in men. The catch is that because this therapy and related research are primarily geared toward men, no one is quite sure what the long-term risks are for women, Davis says. The studies simply have not been done.

Read full, original post: Testosterone Therapy Can Restore Women’s Libido—but Questions Remain

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend